< Back to Publications
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.
|Publication Type||Journal Article|
|Authors||Gong, Y., Zack TI, Morris LG, Lin K., Hukkelhoven E., Raheja R., Tan IL, Turcan S., Veeriah S., Meng S., Viale A., Schumacher SE, Palmedo P., Beroukhim R., and Chan TA|
|Abstract||Coordinate control of different classes of cyclins is fundamentally important for cell cycle regulation and tumor suppression, yet the underlying mechanisms are incompletely understood. Here we show that the PARK2 tumor suppressor mediates this coordination. The PARK2 E3 ubiquitin ligase coordinately controls the stability of both cyclin D and cyclin E. Analysis of approximately 5,000 tumor genomes shows that PARK2 is a very frequently deleted gene in human cancer and uncovers a striking pattern of mutual exclusivity between PARK2 deletion and amplification of CCND1, CCNE1 or CDK4-implicating these genes in a common pathway. Inactivation of PARK2 results in the accumulation of cyclin D and acceleration of cell cycle progression. Furthermore, PARK2 is a component of a new class of cullin-RING-containing ubiquitin ligases targeting both cyclin D and cyclin E for degradation. Thus, PARK2 regulates cyclin-CDK complexes, as does the CDK inhibitor p16, but acts as a master regulator of the stability of G1/S cyclins.|
|Year of Publication||2014|
|Date Published (YYYY/MM/DD)||2014/05/04|